Snowflake Inc vs 10X Genomics Inc — how do they compare? Snowflake Inc trades at $271.69 (market cap $95.09B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Snowflake Inc is far larger — about 17.4× 10X Genomics Inc's market cap. Which is the better fit depends on your goals.
| SNOW | TXG | |
|---|---|---|
Market Cap | $95.09B | $5.48B |
Sector | Technology | Health |
52-Week High | $280.16 | $45.80 |
52-Week Low | $121.11 | $11.34 |
Enterprise Value | $94.90B | $5.02B |
Trailing returns across standard periods
Latest headlines on both assets
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →